BlackRock launches iShares US biotech ETF
TER of 0.35%
BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.
Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using...
More on ETFs
JPMAM expands ETF range with quadruple launch
Listed on the LSE
Ossiam unveils ESG machine learning ETF
TER of 0.65%
BlackRock teams up with MSCI to launch emerging market value ETF
TER of 0.40%
2018 rewind: What were the biggest stories across the ETF industry?
What made the headlines in the sector over the past 12 months?
More news
Update: AXA IM expands senior roles amid restructure
New organisation
Legg Mason opens Dublin office amid Brexit uncertainty
Headed up by Penny Kyle
FCA bans Vanguard consultant over conflict of interests
Ex-Standard life manager Angela Burns
Brexit Blog: No-deal fears increase as May's backstop pleas fail to sway EU leaders
Latest news and analysis
Uncovering the growth versus income debate in Asia and Japan
Talking Strategies: The number of companies in Asia with higher payout ratios have grown since the mid-1990s, but some investors remain wary of searching for income in Asia and Japan. In this video, Jupiter's Jason Pidcock and Dan Carter explain why this...